Istisociclib - Concentra Biosciences
Alternative Names: KB-0742; KI-ARv-03Latest Information Update: 28 Aug 2025
At a glance
- Originator Kronos Bio
- Class Antineoplastics; Cyclopentanes; Diamines; Pyrazolones; Pyrimidines; Small molecules
- Mechanism of Action Cyclin-dependent kinase 9 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Discontinued Non-Hodgkin's lymphoma; Solid tumours
Most Recent Events
- 24 Dec 2024 Chemical structure information added.
- 13 Nov 2024 Discontinued - Phase-I/II for Non-Hodgkin's lymphoma (In adolescents, In children, In the elderly, Second-line therapy or greater, In adults) in USA, Spain, United Kingdom (PO)
- 13 Nov 2024 Discontinued - Phase-I/II for Solid tumours (In adolescents, In children, In the elderly, Second-line therapy or greater, In adults) in USA, Spain, United Kingdom (PO)